Latest Research in Helicobacter Pylori Pathogenesis

Top Research Topics in Helicobacter Pylori Pathogenesis

• Helicobacter pylori-related gastroenterology studies — 51 papers
• Breast Lesions and Carcinomas — 6 papers
• Microscopic Colitis — 3 papers
• Psoriasis: Treatment and Pathogenesis — 1 papers
• Aluminum toxicity and tolerance in plants and animals — 1 papers
• Tattoo and Body Piercing Complications — 1 papers
• Flow Measurement and Analysis — 1 papers
• Pharmaceutical Practices and Patient Outcomes — 1 papers
• Milk Quality and Mastitis in Dairy Cows — 1 papers
• Stochastic processes and financial applications — 1 papers

Highest-Cited Papers

1. School-based hygiene intervention to prevent Helicobacter Pylori infection among children (SHIP HOPE): a cluster-randomized controlled trial
2. Serum Prolactin as a Routine Biomarker in the Assessment of Mastalgia
3. Presentation and Outcome of Granulomatous Mastitis in A Tertiary-Level Hospital
4. Beyond the stomach: a cross-sectional analysis of H. pylori infection and the TyG index in a high-risk population from Southwest China
5. Presentation and Outcome of Granulomatous Mastitis in A Tertiary-Level Hospital
6. Levofloxacin-based concomitant versus sequential therapy for Helicobacter pylori eradication in treatment-naïve Syrian patients: a randomized trial showing no superiority of sequential therapy
7. Serum Prolactin as a Routine Biomarker in the Assessment of Mastalgia
8. Helicobacter pylori genotypes, virulence and antibiotic resistance patterns among outpatients with gastric diseases in representative urban-rural areas of Yunnan, China
9. Putative loss-of-function variants of Helicobacter pylori FecA2 are associated with reduced corpus atrophy and lower gastric cancer risk
10. Oral Helicobacter pylori: a scoping review and pilot study on the PCR-culture detection paradox
11. Association of Interleukin‐17F Polymorphisms (rs763780, rs9382084, rs2397084, and rs12203582) With Gastric Cancer Susceptibility According to Helicobacter pylori Infection Status
12. Population heterogeneity in Helicobacter pylori PMSS1 shapes variable mouse infectivity: derivation of the homogeneous reference strain PMSS2
13. Fourteen-Day Amoxicillin- or Tetracycline-Containing Bismuth Quadruple Therapy versus 14-Day Metronidazole-Based Triple Therapy as the Treatment for Clarithromycin-Resistant Helicobacter pylori Infection: A Multicenter Randomized Controlled Trial
14. Reconsidering First-Line Therapy for Clarithromycin-Resistant Helicobacter pylori in Korea: The Role of Bismuth-Augmented Triple Therapy
15. Sex Differences in Helicobacter pylori Antimicrobial Resistance among 890 Subjects over 20 Years in a Korean Tertiary Hospital
16. Potassium-competitive acid blocker versus proton pump inhibitor as a part of bismuth-based quadruple therapy for treatment of Helicobacter pylori infection: a randomized controlled trial
17. Helicobacter pylori vaccines: from bench to bedside—progress, challenges, and future directions
18. Efficacy and safety of probiotics combined with P-CAB-containing dual therapy for Helicobacter pylori eradication: a meta-analysis
19. Interleukin-17RA polymorphisms rs887796 and rs1468488 are not associated with gastric cancer
20. Randomized controlled trial comparing 7-day fexuprazan-based and 14-day rabeprazole-based triple therapies for Helicobacter pylori eradication

Sub-Regions

• Helicobacter pylori-related gastroenterology studies — 40 papers
• Pharmaceutical Practices and Patient Outcomes — 17 papers
• Advanced Neural Network Applications — 3 papers